Syntara Limited Showcases at Investor Webinar
Pharmaxis Ltd (AU:SNT) has released an update. Clinical stage drug developer Syntara Limited announces its participation in the ShareCafe Small Cap...
Source: biztoc.com
Pharmaxis Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharmaxis Ltd Today - Breaking & Trending Today
Contrasting ProMetic Life Sciences (OTCMKTS:PFSCF) & Pharmaxis (OTCMKTS:PXSLY)
ProMetic Life Sciences (OTCMKTS:PFSCF – Get Free Report) and Pharmaxis (OTCMKTS:PXSLY – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk. Profitability This table compares ProMetic Life Sciences […]
Source: dailypolitical.com
2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
/PRNewswire/ -- The "Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update"...
Source: prnewswire.com
Syntara advances multinational study targeting rare bone marrow cancer myelofibrosis
Deep Dive - Syntara Ltd
Source: proactiveinvestors.com
Syntara doses first patient in bone cancer Phase 2 trial assessing SNT-5505 in combination with ruxolitinib
Syntara Ltd (ASX:SNT, OTC:PMXSF), formerly Pharmaxis Ltd, has dosed the first patient in a phase two clinical trial assessing its pan-LOX inhibitor SNT-5505...
Source: proactiveinvestors.com